Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The companies will work with investigators to share the results with the scientific community
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The hospital hosted a two-day event with top internal and external faculty and medical experts
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
This approval has come from the company's finished dosage form manufacturing facility
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Subscribe To Our Newsletter & Stay Updated
